Glenmark Pharmaceuticals Limited
GLENMARK
주식 순위
#2737
Glenmark Pharmaceuticals Limited, including its associated entities, is a... Glenmark Pharmaceuticals Limited, including its associated entities, is a global pharmaceutical company specializing in the research, development, production, and marketing of medicinal products. Its operational reach spans India, North America, Latin America, Europe, and other international regions. The company's diverse offerings comprise both branded and generic drug formulations, with a strategic emphasis on therapeutic areas such as dermatology, respiratory conditions, and oncology. Additionally, Glenmark manufactures and supplies a variety of active pharmaceutical ingredients. The company's robust product pipeline includes several investigational therapies. Among its clinical-stage assets are ISB 830 (telazorlimab), an OX40 antagonist monoclonal antibody currently in Phase 2b trials for atopic dermatitis; ISB 1302, a HER2 x CD3 bispecific antibody undergoing Phase 1/2 studies for metastatic HER2-positive breast cancer; and ISB 1342, a CD38 x CD3 bispecific antibody in Phase 1 development for relapsed/refractory multiple myeloma. In its preclinical pipeline, Glenmark is advancing ISB 880 for anti-inflammatory applications; the T-cell engagers ISB 1908 and ISB 1909 for oncology indications; ISB 1442, an innate immune engager also targeting oncology; and GRC 39815, a retinoid-related orphan receptor gamma inhibitor aimed at treating chronic obstructive pulmonary disorder (COPD). Among its commercially available products is Ryaltris nasal spray, prescribed for allergic rhinitis. Founded in 1977, Glenmark Pharmaceuticals Limited is headquartered in Mumbai, India.
주가
$24.39
마지막 동기화: 2026-10-19
시가총액
$6.88B
변동 (1일)
-1.20%
변동 (1년)
15.69%
국가
IN
거래 Glenmark Pharmaceuticals Limited (GLENMARK)
카테고리
Healthcare
Glenmark Pharmaceuticals Limited (GLENMARK)의 주식 분할 이력
Glenmark Pharmaceuticals Limited 주식 (심볼: GLENMARK)은 총 3회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Sep 10, 2007에 발생했습니다.
Oct 23, 2003 이전에 매수한 GLENMARK 주식 1주는 현재 20주의 GLENMARK 주식에 해당합니다.
가장 최근의 분할은 Sep 10, 2007에 발생했습니다.
Oct 23, 2003 이전에 매수한 GLENMARK 주식 1주는 현재 20주의 GLENMARK 주식에 해당합니다.
주식 분할 목록
| 연도 | 주식 분할 | 배수 | 누적 배수 |
|---|---|---|---|
| 2007-09-10 | 2:1 | x2 | x20 |
| 2005-03-04 | 2:1 | x2 | x10 |
| 2003-10-23 | 5:1 | x5 | x5 |
유사 기업 또는 경쟁사의 주식 분할
| 회사 | 주식 분할 횟수 | 누적 배수 | 국가 |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
